• Home
  • Obesity definition
  • Obesity Health Risk
  • Semaglutide loss weight
  • Evaluation and Follow up
  • new prices for 2024
  • The Procedure

Contact us admin@sanchezcazau.com or text message to 305 890 6903

  • Home
  • Obesity definition
  • Obesity Health Risk
  • Semaglutide loss weight
  • Evaluation and Follow up
  • new prices for 2024
  • The Procedure

About medically supervised weight loss with semaglutide

SEMAGLUTIDE FOR WEIGHT LOSS

 Semaglutide is an FDA-approved injectable glucagon-like peptide-1 (GLP-1) agonist that helps with long-term weight loss and weight management. Patients can expect to lose weight with weekly Semaglutide injections.  When GLP-1 is released, it targets various receptors in the body to help stimulate insulin release, while also suppressing glucagon, slowing gastric emptying, and increasing the feeling of fullness. Semaglutide works by reducing overall body fat and suppressing the appetite. 

 Semaglutide  is the active ingredient in popular weight loss medication Wegovy and Ozempic. 


 

Click Below for more information ....

Evaluation and Follow up

Copyright © 2024 medically supervised weight loss with semaglutide - Todos los derechos reservados.

Con tecnología de GoDaddy

  • Home

Este sitio web utiliza cookies

Usamos cookies para analizar el tráfico del sitio web y optimizar tu experiencia en el sitio. Al aceptar nuestro uso de cookies, tus datos se agruparán con los datos de todos los demás usuarios.

Aceptar